Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ANKRD11 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA540736
Description
Peptide sequence: KRKLPFTAGA NGEQKDSDTE KQGPERKRIK KEPVTRKAGL LFGMGLSGIR Sequence homology: Cow: 100%; Dog: 100%; Guinea Pig: 93%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 86%.
ANKRD11 is a member of a novel family of ankyrin repeats containing cofactors (ANCOs) that interact with p160 coactivators to inhibit ligand-dependent transactivation. ANKRD11 encodes a large nuclear protein with five ankyrin repeats, and parts of its sequences have been reported as nasopharyngeal carcinoma susceptibility protein and medulloblastoma antigen. This gene also colocalizes and interacts with histone deacetylases.
Specifications
ANKRD11 | |
Polyclonal | |
Unconjugated | |
ANKRD11 | |
2410104C19Rik; 3010027A04Rik; 6330578C09Rik; 9530048I21Rik; AA930108; ANCO1; ANCO-1; ANKRD11; ankyrin repeat domain 11; ankyrin repeat domain-containing protein 11; Ankyrin repeat-containing cofactor 1; fc59e05; fi04c06; Gm176; LOW QUALITY PROTEIN: ankyrin repeat domain-containing protein 11; LZ16; nasopharyngeal carcinoma susceptibility protein; T13; truncated ankyrin repeat domain 11 aberrant transcript 1; truncated ankyrin repeat domain 11 aberrant transcript 2; wu:fc59e05; wu:fi04c06; Yod | |
Rabbit | |
Protein A | |
RUO | |
29123 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Immunohistochemistry, Western Blot | |
1 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
Q6UB99 | |
ANKRD11 | |
Synthetic peptide directed towards the N-terminal of human ANKRD11 (aa 57-106). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction